Oncolytics Biotech Inc. (TSE:ONC – Get Free Report)’s stock price crossed above its two hundred day moving average during trading on Thursday . The stock has a two hundred day moving average of C$1.40 ...
For decades, treating lung cancer has been like trying to hit a moving target in the dark. Just when doctors think they've found an effective treatment, the cancer adapts and escapes. Now, a team of ...
AbbVie (NYSE: ABBV) recently announced new results from two ongoing clinical trials evaluating epcoritamab, a CD3xCD20 bispecific T-cell-engaging antibody administered subcutaneously, in adult ...